indapamide has been researched along with Diseases, Metabolic in 3 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "to assess the potential of fixed perindopril/indapamide combination (FPIC) to improve angioprotection in patients with arterial hypertension (AP) with various efficacy of preceding therapy with combination of losartan and hydrochlorothiazide (HCTZ)." | 7.85 | [Optimization of Control of Blood Pressure, Metabolic Disorders and Target Organs Protection With Fixed Perindopril and Indapamide Combination in Treated Patients With Arterial Hypertension]. ( Chumachek, EV; Hripaeva, VJ; Ledyaeva, AA; Nedogoda, SV; Palashkin, RV; Salasyuk, AS; Smirnova, VO; Tsoma, VV, 2017) |
| "to assess the potential of fixed perindopril/indapamide combination (FPIC) to improve angioprotection in patients with arterial hypertension (AP) with various efficacy of preceding therapy with combination of losartan and hydrochlorothiazide (HCTZ)." | 3.85 | [Optimization of Control of Blood Pressure, Metabolic Disorders and Target Organs Protection With Fixed Perindopril and Indapamide Combination in Treated Patients With Arterial Hypertension]. ( Chumachek, EV; Hripaeva, VJ; Ledyaeva, AA; Nedogoda, SV; Palashkin, RV; Salasyuk, AS; Smirnova, VO; Tsoma, VV, 2017) |
| "Telmisartan was more effective, whereas indapamide had better pharmacoeconomic benefits." | 2.80 | Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure. ( Liu, Z; Lu, F; Peng, J; Tang, M; Wang, Z; Zhang, H; Zhang, W; Zhao, Y; Zhong, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, J | 1 |
| Zhao, Y | 1 |
| Zhang, H | 1 |
| Liu, Z | 1 |
| Wang, Z | 1 |
| Tang, M | 1 |
| Zhong, M | 1 |
| Lu, F | 1 |
| Zhang, W | 1 |
| Nedogoda, SV | 1 |
| Chumachek, EV | 1 |
| Ledyaeva, AA | 1 |
| Tsoma, VV | 1 |
| Salasyuk, AS | 1 |
| Smirnova, VO | 1 |
| Hripaeva, VJ | 1 |
| Palashkin, RV | 1 |
| Passa, P | 1 |
2 trials available for indapamide and Diseases, Metabolic
| Article | Year |
|---|---|
Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; China; Double-Blind Method | 2015 |
[Cicletanine tolerance in hypertensive patients with metabolic disorders].
Topics: Antihypertensive Agents; Diuretics; Double-Blind Method; Drug Evaluation; Female; Humans; Hypertensi | 1989 |
1 other study available for indapamide and Diseases, Metabolic
| Article | Year |
|---|---|
[Optimization of Control of Blood Pressure, Metabolic Disorders and Target Organs Protection With Fixed Perindopril and Indapamide Combination in Treated Patients With Arterial Hypertension].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; H | 2017 |